2024 – Atamyo Therapeutics

Scientific Publications

January 07, 2025

An engineered AAV targeting integrin Alpha V Beta 6 presents improved myotropism across species

Hong et al., 2024 Nature Communications Read more

October 14, 2024

Preliminary Results from a Phase 1-2 Gene Therapy Study of ATA-100, AAV9 Vector Encoding FKRP, in Patients with Limb Girdle Muscular Dystrophy R9